Oliver Dietrich

Oliver Dietrich

Auto-generated profile, based on publicly available information

Oliver Dietrich

Institute of Computational Biology, Computational Health Center, Helmholtz Munich, Neuherberg, Germany

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in Cell
Verified
Journal Article
Closed access
JSJonas Schulte-Schrepping
Jonas Schulte-Schrepping
NRNico Reusch
Nico Reusch
DPDaniela Paclik
Daniela Paclik
KBKevin Baßler
Kevin Baßler
SSStephan Schlickeiser
Stephan Schlickeiser
JZJohn Ziebuhr
John Ziebuhr

22 February 2021 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
MVMatteo Claudio Da Vià
Matteo Claudio Da Vià
ODOliver Dietrich
Oliver Dietrich
MTMarietta Truger
Marietta Truger
PAPanagiota Arampatzi
Panagiota Arampatzi
JDJohannes Duell
Johannes Duell
Leo RascheLeo Rasche
Leo Rasche

18 January 2021 in Nature Cell Biology
Verified
Journal Article
Open access
PDF file
CCCindrilla Chumduri
Cindrilla Chumduri
RGRajendra Kumar Gurumurthy
Rajendra Kumar Gurumurthy
HBHilmar Berger
Hilmar Berger
ODOliver Dietrich
Oliver Dietrich
NKNaveen Kumar
Naveen Kumar
TMThomas Meyer
Thomas Meyer
The transition zones of the squamous and columnar epithelia constitute hotspots for the emergence of cancer, often preceded by metaplasia, in which one epithelial type is replaced by another. It remains unclear how the epithelial spatial organization is maintained and how the transition zone niche is remodelled during metaplasia. Here we used single-cell RNA sequencing to characterize epithelial subpopulations and the underlying stromal compartment of endo- and ectocervix, encompassing the transition zone. Mouse lineage tracing, organoid culture and single-molecule RNA in situ hybridizations revealed that the two epithelia derive from separate cervix-resident lineage-specific stem cell populations regulated by opposing Wnt signals from the stroma. Using a mouse model of cervical metaplasia, we further show that the endocervical stroma undergoes remodelling and increases expression of the Wnt inhibitor Dickkopf-2 (DKK2), promoting the outgrowth of ectocervical stem cells. Our data indicate that homeostasis at the transition zone results from divergent stromal signals, driving the differential proliferation of resident epithelial lineages.

22 February 2024 in Blood
Verified
Journal Article
Closed access
PDF file
JDJohannes Duell
Johannes Duell
ALAlexander Michael Leipold
Alexander Michael Leipold
SASilke Appenzeller
Silke Appenzeller
VFViktoria Fuhr
Viktoria Fuhr
HRHilka Rauert-Wunderlich
Hilka Rauert-Wunderlich
Leo RascheLeo Rasche
Leo Rasche
CD19 chimeric antigen receptor (CAR) T cells and CD20 targeting T-cell–engaging bispecific antibodies (bispecs) have been approved in B-cell non-Hodgkin lymphoma lately, heralding a new clinical setting in which patients are treated with both approaches, sequentially. The aim of our study was to investigate the selective pressure of CD19- and CD20-directed therapy on the clonal architecture in lymphoma. Using a broad analytical pipeline on 28 longitudinally collected specimen from 7 patients, we identified truncating mutations in the gene encoding CD20 conferring antigen loss in 80% of patients relapsing from CD20 bispecs. Pronounced T-cell exhaustion was identified in cases with progressive disease and retained CD20 expression. We also confirmed CD19 loss after CAR T-cell therapy and reported the case of sequential CD19 and CD20 loss. We observed branching evolution with re-emergence of CD20+ subclones at later time points and spatial heterogeneity for CD20 expression in response to targeted therapy. Our results highlight immunotherapy as not only an evolutionary bottleneck selecting for antigen loss variants but also complex evolutionary pathways underlying disease progression from these novel therapies.

13 March 2025 in Nature Methods
Verified
Journal Article
Open access
PDF file
LZLuke Zappia
Luke Zappia
SRSabrina Richter
Sabrina Richter
CRCiro Ramírez-Suástegui
Ciro Ramírez-Suástegui
RKRaphael Kfuri-Rubens
Raphael Kfuri-Rubens
LVLarsen Vornholz
Larsen Vornholz
FTFabian J. Theis
Fabian J. Theis
The availability of single-cell transcriptomics has allowed the construction of reference cell atlases, but their usefulness depends on the quality of dataset integration and the ability to map new samples. Previous benchmarks have compared integration methods and suggest that feature selection improves performance but have not explored how best to select features. Here, we benchmark feature selection methods for single-cell RNA sequencing integration using metrics beyond batch correction and preservation of biological variation to assess query mapping, label transfer and the detection of unseen populations. We reinforce common practice by showing that highly variable feature selection is effective for producing high-quality integrations and provide further guidance on the effect of the number of features selected, batch-aware feature selection, lineage-specific feature selection and integration and the interaction between feature selection and integration models. These results are informative for analysts working on large-scale tissue atlases, using atlases or integrating their own data to tackle specific biological questions.

11 November 2021 in Journal of Innate Immunity
Verified
Journal Article
Open access
PDF file
ODOliver Dietrich
Oliver Dietrich
AHAlexander Heinz
Alexander Heinz
OGOliver Goldmann
Oliver Goldmann
RGRobert Geffers
Robert Geffers
ABAndreas Beineke
Andreas Beineke
EMEva Medina
Eva Medina
Myeloid-derived suppressor cells (MDSCs) are a compendium of immature myeloid cells that exhibit potent T-cell suppressive capacity and expand during pathological conditions such as cancer and chronic infections. Although well-characterized in cancer, the physiology of MDSCs in the infection setting remains enigmatic. Here, we integrated single-cell RNA sequencing (scRNA-seq) and functional metabolic profiling to gain deeper insights into the factors governing the generation and maintenance of MDSCs in chronic Staphylococcus aureus infection. We found that MDSCs originate not only in the bone marrow but also at extramedullary sites in S. aureus-infected mice. scRNA-seq showed that infection-driven MDSCs encompass a spectrum of myeloid precursors in different stages of differentiation, ranging from promyelocytes to mature neutrophils. Furthermore, the scRNA-seq analysis has also uncovered valuable phenotypic markers to distinguish mature myeloid cells from immature MDSCs. Metabolic profiling indicates that MDSCs exhibit high glycolytic activity and high glucose consumption rates, which are required for undergoing terminal maturation. However, rapid glucose consumption by MDSCs added to infection-induced perturbations in the glucose supplies in infected mice hinders the terminal maturation of MDSCs and promotes their accumulation in an immature stage. In a proof-of-concept in vivo experiment, we demonstrate the beneficial effect of increasing glucose availability in promoting MDSC terminal differentiation in infected mice. Our results provide valuable information of how metabolic alterations induced by infection influence reprogramming and differentiation of MDSCs.